Arrowhead Research (ARWR) Stock: Buy, Sell, or Hold?
ARWR - Arrowhead Research Corporation
$58.36
-0.48 (-0.82%)
▼
5d:
-0.24%
30d:
-12.84%
90d:
-31.82%
BUY
MODERATE Confidence
Analysis Updated: Oct 22, 2026 12:00 AM ET
Earnings: Nov 24, 2026
Get Alerted When ARWR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: ARWR shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: ARWR shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: ARWR is currently trading at $58.36, which is considered slightly low relative to its 30-day fair value range of $58.83 to $69.21.
Technical Outlook: Technically, ARWR is in a uptrend. Immediate support is located at $55.83, while resistance sits at $62.99.
Market Sentiment: ARWR scores 64/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $107.71 (+83.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ARWR is in a uptrend. Immediate support is located at $55.83, while resistance sits at $62.99.
Market Sentiment: ARWR scores 64/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $107.71 (+83.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$58.83 -
$69.21
Company Quality Score
60/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
94.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (64/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 83.1% below Wall St target ($107.71)
- BULLISH: Bottoming setup score 64/100 — corrected, stabilizing, and turning up
Trading Range Analysis
30-Day Trading Range
$58.83 -
$69.21
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$55.83
Resistance Level
$62.99
Current Trend
Uptrend
Technical data as of
Oct 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-11.82
Wall Street Target
$107.71
(+83.1%)
Revenue Growth (YoY)
171.0%
Earnings Growth (YoY)
9.8%
Profit Margin
-47.8%
Share & Embed Analysis
Last updated: October 22, 2026 4:41 PM ET
Data refreshes hourly during market hours. Next update: 5:41 PM
Data refreshes hourly during market hours. Next update: 5:41 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ARWR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
INSM
Insmed Inc |
STRONG BUY
24 analysts |
$197 | 52 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
22 analysts |
$109 | 61 BUY |
|
MDGL
Madrigal Pharmaceuticals… |
STRONG BUY
19 analysts |
$686 | 62 BUY |
|
CRSP
Crispr Therapeutics AG |
BUY
23 analysts |
$86 | 66 BUY |
|
CGON
CG Oncology, Inc. Common… |
STRONG BUY
15 analysts |
$91 | 64 BUY |
Advanced ARWR Option Strategies
Professional options setups generated by AI based on today's ARWR price and gamma walls.
